Abstract
NicOx is developing NCX-701, a nitric oxide-releasing derivative of paracetamol (acetaminophen), for the potential treatment of inflammation and pain. The compound is currently undergoing phase III clinical trials.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 755-759 |
| Number of pages | 5 |
| Journal | Current Opinion in Investigational Drugs |
| Volume | 5 |
| Issue number | 7 |
| State | Published - Jul 1 2004 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery